Log In
Print
BCIQ
Print
Print this Print this
 

Memogain, pro-galantamine (Gln 1062)

  Manage Alerts
Collapse Summary General Information
Company Neurodyn Inc.
DescriptionProdrug of galantamine, a nicotinic acetylcholine receptor sensitizer
Molecular Target Nicotinic acetylcholine receptor (nAchR)
Mechanism of ActionNicotinic receptor modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today